AD/PD 2026: Blood Biomarker Identifies Tau Pathology in Alzheimer's Disease

Fernando Gonzalez-Ortiz, MD, PhD, Postdoctor, University of Gothenburg, Sweden, presents in this MEDtalk from the AD/PD 2026 Conference the results of his study, which highlights phosphorylated tau at serine 262 as an MTBR-tau243 blood-based biomarker that can specifically identify tau clusters (tangles) in the brain of individuals with Alzheimer’s disease.